AB-M101

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAB-M101
Drug Alias NameClostridium difficile associated diarrhea (CDAD) program (Assembly Biosciences)AB-M101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsDiarrheaClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAssembly Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAssembly Biosciences Inc
Active IndicationsN/A
Inactive IndicationsDiarrheaClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A